Young Joseph's most recent trade in Vera Therapeutics Inc - Ordinary Shares - Class A was a trade of 21,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 10,740 | 61,946 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 20,651 | 69,349 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.87 per share. | 15 May 2024 | 18,151 | 69,357 | - | 7.9 | 142,848 | Class A Common Stock |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Sale of securities on an exchange or to another person at price $ 42.22 per share. | 15 May 2024 | 18,151 | 51,206 | - | 42.2 | 766,317 | Class A Common Stock |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.94 per share. | 15 May 2024 | 8,221 | 61,392 | - | 3.9 | 32,387 | Class A Common Stock |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Sale of securities on an exchange or to another person at price $ 42.17 per share. | 15 May 2024 | 8,221 | 53,171 | - | 42.2 | 346,680 | Class A Common Stock |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 8,221 | 58,589 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Sale of securities on an exchange or to another person at price $ 43.03 per share. | 15 May 2024 | 2,500 | 51,206 | - | 43.0 | 107,573 | Class A Common Stock |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.87 per share. | 15 May 2024 | 2,500 | 53,706 | - | 7.9 | 19,675 | Class A Common Stock |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Sale of securities on an exchange or to another person at price $ 42.68 per share. | 15 May 2024 | 1,965 | 51,206 | - | 42.7 | 83,866 | Class A Common Stock |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 10 Apr 2024 | 5,714 | 53,171 | - | 40 | 228,560 | Class A Common Stock |
| Vera Therapeutics Inc | Young Joseph | SVP, FINANCE, CHIEF ACCT OFFCR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 81,250 | 81,250 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc | Joseph Young | SVP, FINANCE, CHIEF ACCT OFFCR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 21,875 | 57,054 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc | Joseph Young | SVP, Finance, Chief Acct Offcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2023 | 10,000 | 66,810 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc | Joseph Young | SVP, Finance, Chief Acct Offcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.94 per share. | 05 Jul 2023 | 10,000 | 32,679 | - | 3.9 | 39,396 | Class A Common Stock |
| Vera Therapeutics Inc | Joseph Young | SVP, Finance, Chief Acct Offcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc | Joseph Young | SVP, Finance, Chief Acct Offcr | Purchase of securities on an exchange or from another person at price $ 7.00 per share. | 06 Feb 2023 | 5,714 | 22,679 | - | 7 | 39,998 | Class A Common Stock |
| Vera Therapeutics Inc | Joseph Young | SVP, Finance, Chief Acct Offcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2022 | 15,000 | 16,148 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc | Joseph Young | SVP, Finance, Chief Acct Offcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 36,729 | 36,729 | - | - | Stock Option (right to buy) |